Health Catalyst Inc
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
HCAT$1.44-4.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Health Catalyst, Inc. Consolidated Statements of Operations
Consolidated Statements of Operations
(in thousands, except per share data)
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Revenue(1): | |||
| Technology | $187,583 | $176,288 | $147,718 |
| Professional services | 108,355 | 99,948 | 94,208 |
| Total revenue | 295,938 | 276,236 | 241,926 |
| Cost of revenue, excluding depreciation and amortization(1): | |||
| Technology | 62,474 | 56,642 | 47,516 |
| Professional services | 101,631 | 86,407 | 76,838 |
| Total cost of revenue, excluding depreciation and amortization | 164,105 | 143,049 | 124,354 |
| Operating expenses: | |||
| Sales and marketing | 67,321 | 87,514 | 75,027 |
| Research and development | 72,627 | 75,680 | 62,733 |
| General and administrative | 76,559 | 61,701 | 85,934 |
| Depreciation and amortization | 42,223 | 48,297 | 37,528 |
| Total operating expenses | 258,730 | 273,192 | 261,222 |
| Loss from operations | (126,897) | (140,005) | (143,650) |
| Interest and other income (expense), net | 9,106 | (1,678) | (16,458) |
| Loss before income taxes | (117,791) | (141,683) | (160,108) |
| Income tax provision (benefit) | 356 | (4,280) | (6,898) |
| Net loss | $(118,147) | $(137,403) | $(153,210) |
| Net loss per share, basic | $(2.09) | $(2.56) | $(3.23) |
| Net loss per share, diluted | $(2.09) | $(2.63) | $(3.23) |
| Weighted-average shares outstanding used in calculating net loss per share, basic | 56,418 | 53,722 | 47,495 |
| Weighted-average shares outstanding used in calculating net loss per share, diluted | 56,418 | 54,080 | 47,495 |
(1)Includes amounts attributable to related party transactions. See Note 18 for further details.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.